Friedreich's Ataxia (FA) is a rare genetic neurodegenerative disorder that primarily affects the nervous system and muscles, leading to progressive loss of coordination, mobility, and speech. The Friedreich's Ataxia Drug Market is driven by the growing need for effective treatments for this debilitating condition, as there are currently no FDA-approved therapies that can cure or fully...